CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-02 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +10,000 | $2.80 | $28K | 83,586 |
| 2016-09-02 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Employee Stock Option (right to buy) | −10,000 | 25,000 | ||
| 2016-06-08 | CATLIN AVERY W Sr. VP & CFO | Grant or award · Incentive Stock Option | +135,000 | 135,000 | ||
| 2016-06-03 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +20,000 | $2.80 | $56K | 70,739 |
| 2016-06-03 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +2,847 | $4.50 | $13K | 73,586 |
| 2016-06-03 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Option | −20,000 | 0 | ||
| 2016-06-03 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Option | −2,847 | 5,000 | ||
| 2016-03-09 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +15,000 | $2.80 | $42K | 50,739 |
| 2016-03-09 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Option | −15,000 | 20,000 | ||
| 2015-11-23 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +25,000 | $8.52 | $213K | 60,109 |
| 2015-11-23 | CATLIN AVERY W Sr. VP & CFO | Sale | −25,000 | $18.00 | $450K | 35,109 |
| 2015-11-23 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Non-Qualified Stock Option | −25,000 | 0 | ||
| 2015-09-11 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +10,000 | $4.50 | $45K | 35,109 |
| 2015-09-11 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Option | −10,000 | 7,847 | ||
| 2015-06-15 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +25,000 | $8.52 | $213K | 49,609 |
| 2015-06-15 | CATLIN AVERY W Sr. VP & CFO | Sale | −25,000 | $24.59 | $615K | 24,609 |
| 2015-06-15 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Non-Qualified Stock Option | −25,000 | 0 | ||
| 2015-06-10 | CATLIN AVERY W Sr. VP & CFO | Grant or award · Incentive Stock Option | +92,000 | 92,000 | ||
| 2014-09-08 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +10,000 | $4.50 | $45K | 24,609 |
| 2014-09-08 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Options | −10,000 | 17,847 |
Page 1 of 2 · 27 trades